Seaweed-derived Rhamnan Sulfate and Vascular Function
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Dec 6, 2022
Trial Information
Current as of January 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether a supplement derived from seaweed, known as rhamnan sulfate, can improve blood vessel health in middle-aged and older adults who have at least one risk factor for cardiovascular disease, such as high cholesterol, high blood pressure, obesity, or elevated blood sugar levels. The researchers believe that taking this supplement for a short period could help improve important markers of how well the blood vessels function.
To participate in the trial, individuals must be middle-aged or older and have at least one of the mentioned risk factors for cardiovascular disease. They should also have a body mass index (BMI) of less than 40. However, people with certain health issues like digestive or kidney disorders, those who are pregnant or breastfeeding, or those who engage in very intense physical activity more than three times a week are not eligible to join. Participants can expect to take the supplement and undergo assessments to see how their vascular health changes throughout the study. This trial is currently looking for volunteers, and everyone is welcome to apply, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least one risk factor for cardiovascular disease (e.g., dyslipidemia, hypertension, obesity, impaired fasting glucose)
- • a BMI of \<40 kg/m2
- Exclusion Criteria:
- • gastrointestinal disorders and/or renal disease
- • pregnancy or lactation
- • strenuous physical activity (\>3 times/week)
- • alcohol abuse
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials